Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging.
Treatment of acute transverse myelitis and its early complications.
Laquinimod in multiple sclerosis.
Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Imaging outcomes for trials of remyelination in multiple sclerosis.
First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Neuroprotective effect of masitinib in rats with postischemic stroke.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Treatment of neuromyelitis optica.
Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
The role of T cell apoptosis in nervous system autoimmunity.
First proof for rituximab in IgG4-related disease
Application of fullerenes in nanomedicine: an update.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.

Pages